Tag Archives: market

FiercePharmaAsia—Aducanumab Alzheimer’s flop; Keytruda’s Chinese market; Samsung BioLogics probe

Biogen’s and Eisai’s stocks were dealt a huge blow as the phase 3 program of Alzheimer’s candidate aducanumab was terminated early for futility. Despite challenges from lower-priced domestic rivals, Merck & Co.’s Keytruda could still see blockbuster sales in China, a group of analysts said. Prosecutors raided Korea Exchange as part of an investigation into Samsung… Read More »

Healthcare AI market expected to surge from $2.1 to $36.1 billion by 2025

The healthcare artificial intelligence market is expected to grow from $ 2.1 billion in 2018 to $ 36.1 billion by 2025, at a compound annual growth rate of 50.2 percent during the forecast period, according to market research published by ReportLinker. Increasingly large and complex data sets available in the form of big data, and… Read More »